Literature DB >> 11296946

Correlations between matrix metalloproteinase-9 and adenosine deaminase isozymes in synovial fluid from patients with rheumatoid arthritis.

S Iwaki-Egawa1, H Matsuno.   

Abstract

OBJECTIVE: To clarify the significance of increased adenosine deaminase (ADA) isozyme activities in synovial fluid (SF) from patients with rheumatoid arthritis (RA).
METHODS: ADA isozyme activities were measured using colorimetric assays. Concentrations of matrix metalloproteinase-9 (MMP-9) were measured by ELISA.
RESULTS: Levels of ADA isozyme activities in RA SF were significantly higher than those from patients with osteoarthritis and patients with traumatic injuries. Significant positive correlations between MMP-9 concentration and ADA activities were observed in RA SF (MMP-9 vs total ADA: r = 0.880; vs ADA1: r = 0.829; vs ADA2: r = 0.823; p < 0.001).
CONCLUSION: Elevated levels of ADA activities were found in SF from patients with RA. There were significant positive correlations between MMP-9 and ADA isozymes. These results may reflect the inflammatory condition of patients with RA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11296946

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern.

Authors:  Reza Saghiri; Niloufar Ghashghai; Shafieh Movaseghi; Pegah Poursharifi; Shohreh Jalilfar; Manijeh Ahmadi Bidhendi; Leila Ghazizadeh; Mina Ebrahimi-Rad
Journal:  Rheumatol Int       Date:  2011-02-25       Impact factor: 2.631

2.  Inflammageing assessed by MMP9 in normal Japanese individuals and the patients with Werner syndrome.

Authors:  Makoto Goto; Junji Chiba; Masaaki Matsuura; Sachiko Iwaki-Egawa; Yasuhiro Watanabe
Journal:  Intractable Rare Dis Res       Date:  2016-05

3.  Comparison of adenosine deaminase levels in serum and synovial fluid between patients with rheumatoid arthritis and osteoarthritis.

Authors:  Zahra Zakeri; Shahrokh Izadi; Abassali Niazi; Zohre Bari; Soodabeh Zendeboodi; Mansoor Shakiba; Mohammadali Mashhadi; Behzad Narouie; Mohammad Ghasemi-Rad
Journal:  Int J Clin Exp Med       Date:  2012-04-06

Review 4.  Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?

Authors:  Aleksi Sedo; Jonathan S Duke-Cohan; Eva Balaziova; Liliana R Sedova
Journal:  Arthritis Res Ther       Date:  2005-10-26       Impact factor: 5.156

5.  Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis.

Authors:  Sai Krishna Srimadh Bhagavatham; Prakash Khanchandani; Vishnu Kannan; Damodaram Potikuri; Divya Sridharan; Sujith Kumar Pulukool; Ashwin Ashok Naik; Rajesh Babu Dandamudi; Sai Mangala Divi; Ashish Pargaonkar; Rahul Ray; Saibharath Simha Reddy Santha; Polani B Seshagiri; K Narasimhan; Narsimulu Gumdal; Venketesh Sivaramakrishnan
Journal:  Sci Rep       Date:  2021-07-23       Impact factor: 4.379

Review 6.  Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity.

Authors:  Sara Signa; Arinna Bertoni; Federica Penco; Roberta Caorsi; Alessia Cafaro; Giuliana Cangemi; Stefano Volpi; Marco Gattorno; Francesca Schena
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.